Next generation sequencing efforts, while demonstrating that GATA-3-associated T-cell neoplasms are genetically distinct, also demonstrate that “high-risk” mutations and copy number variants, including p53 loss, are preferentially and recurrently observed in these lymphomas. This evidence concerns the gene TP53 and lymphoma.